Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT
Journal of Gastroenterology, 05/07/2012
Inoue T et al. – The diagnostic ability of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd–EOB–DTPA)–enhanced magnetic resonance imaging (MRI) for hypervascular hepatocellular carcinomas (HCCs) less than 2 cm was significantly higher than that of multi–detector row computed tomography (MDCT). For hypovascular tumors, the detection sensitivity of hepatobiliary phase images of Gd–EOB–DTPA–enhanced MRI was significantly higher than that of dynamic Gd–EOB–DTPA–enhanced MRI and dynamic MDCT. It was difficult to distinguish between dysplastic nodules (DNs) and hypovascular well–differentiated HCCs based on the EOB enhancement ratio.
